TrialInvestigational new drugs2016

A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer.

Christos E Kyriakopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.